These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 3015385

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage.
    Koyama K, Kagamu H, Miura S, Hiura T, Miyabayashi T, Itoh R, Kuriyama H, Tanaka H, Tanaka J, Yoshizawa H, Nakata K, Gejyo F.
    Clin Cancer Res; 2008 Nov 01; 14(21):6770-9. PubMed ID: 18980970
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [T-lymphocyte subsets and serum carcinoembryonic antigen in patients with lung cancer and its dynamic changes after therapy].
    Zhang SC.
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Dec 01; 14(6):336-9, 376. PubMed ID: 1667986
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.
    Okita R, Saeki T, Takashima S, Yamaguchi Y, Toge T.
    Oncol Rep; 2005 Nov 01; 14(5):1269-73. PubMed ID: 16211295
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
    Ito M, Suzuki H, Yamashita N, Sugiyama E, Maruyama M, Sato M, Iwata M, Yano S.
    Anticancer Res; 1984 Nov 01; 4(6):375-8. PubMed ID: 6097158
    [Abstract] [Full Text] [Related]

  • 8. [Significance of human Tr cell in gastric cancer --with special reference to suppressor cell activity].
    Itagaki E, Toge T, Tanada M, Hamamoto S, Seto Y, Kohno H, Hattori T.
    Gan To Kagaku Ryoho; 1984 Jan 01; 11(1):123-9. PubMed ID: 6230053
    [Abstract] [Full Text] [Related]

  • 9. Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.
    Yoshimura C, Nomura S, Kanazawa S, Kuwana M, Yamaguchi K, Fukuhara S.
    J Cancer Res Clin Oncol; 2002 Jan 01; 128(1):29-36. PubMed ID: 11862469
    [Abstract] [Full Text] [Related]

  • 10. Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis.
    Fox RI, Fong S, Sabharwal N, Carstens SA, Kung PC, Vaughan JH.
    J Immunol; 1982 Jan 01; 128(1):351-4. PubMed ID: 6976376
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH.
    Cancer Res; 2001 Jun 15; 61(12):4766-72. PubMed ID: 11406550
    [Abstract] [Full Text] [Related]

  • 13. Exogenous interleukin 2 regulates interleukin 6 and nitric oxide but not interferon gamma and tumor necrosis factor alpha production in bronchoalveolar leukocytes from patients with small cell lung cancer.
    Cembrzyńska-Nowak M, Bieńkowska M, Szklarz E.
    Arch Immunol Ther Exp (Warsz); 1998 Jun 15; 46(6):367-74. PubMed ID: 9883316
    [Abstract] [Full Text] [Related]

  • 14. Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry.
    Ito N, Nakamura H, Tanaka Y, Ohgi S.
    Cancer; 1999 Jun 01; 85(11):2359-67. PubMed ID: 10357406
    [Abstract] [Full Text] [Related]

  • 15. Immunocompetence in lung cancer patients: analysis of serological and cellular parameters.
    Pierri I, Rogna S, Tavano A, Setti M, Scudeletti M, Ratto G, Motta G, Indiveri F.
    Cancer Detect Prev; 1988 Jun 01; 13(2):95-101. PubMed ID: 3242825
    [Abstract] [Full Text] [Related]

  • 16. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
    Vural B, Chen LC, Saip P, Chen YT, Ustuner Z, Gonen M, Simpson AJ, Old LJ, Ozbek U, Gure AO.
    Cancer; 2005 Jun 15; 103(12):2575-83. PubMed ID: 15880380
    [Abstract] [Full Text] [Related]

  • 17. Suppression of B-lymphocyte function by T-lymphocytes in patients with advanced lung cancer.
    Venkataraman M, Rao DS, Levin RD, Westerman MP.
    J Natl Cancer Inst; 1985 Jan 15; 74(1):37-41. PubMed ID: 3155815
    [Abstract] [Full Text] [Related]

  • 18. Anti-survivin antibody responses in lung cancer.
    Karanikas V, Khalil S, Kerenidi T, Gourgoulianis KI, Germenis AE.
    Cancer Lett; 2009 Sep 18; 282(2):159-66. PubMed ID: 19380192
    [Abstract] [Full Text] [Related]

  • 19. In vivo effects of a single infusion of theophylline on human peripheral blood lymphocytes.
    Pardi R, Zocchi MR, Ferrero E, Ciboddo GF, Inverardi L, Rugarli C.
    Clin Exp Immunol; 1984 Sep 18; 57(3):722-8. PubMed ID: 6088140
    [Abstract] [Full Text] [Related]

  • 20. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
    Hadjipetrou-Kourounakis L, Tsougranis A.
    Biochem Exp Biol; 1980 Sep 18; 16(4):357-64. PubMed ID: 6285942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.